|
ProhanceDrug - Prohance The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Gadoteridol
Strength -
279.3MG/ML
Applicant -
BRACCO
New Drug Application (NDA) Number -
020131
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Nov 16, 1992
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Bracco Diagnostics Inc
Prohance
Omniscan 287mg/ml Injectable; Injection
Magnevist 469.01mg/ml Injectable; Injection Magnevist 469.01mg/ml Injectable; Injection Prohance 279.3mg/ml Injectable; Injection Multihance 10.58gm/20ml (529mg/ml) Injectable; Intravenous Multihance 2.645gm/5ml (529mg/ml) Injectable; Intravenous Multihance 5.29gm/10ml (529mg/ml) Injectable; Intravenous Multihance 7.935gm/15ml (529mg/ml) Injectable; Intravenous Multihance Multipack 26.45gm/50ml (529mg/ml) Injectable; Intravenous Multihance Multipack 52.9gm/100ml (529mg/ml) Injectable; Intravenous NewDrugInformation |